Liraglutide for the treatment of obesity

South African Family Practice

 
 
Field Value
 
Title Liraglutide for the treatment of obesity
 
Creator Bronkhorst, Elmien Schellack, Natalie
 
Subject — liraglutide; overweight; obesity; weight-loss; incretin; GLP-1; type 2 diabetes mellitus
Description Obesity and being overweight have become significant global health concerns, and may actually be seen as chronic disease conditions or even as a worldwide epidemic. In addition to the necessary life-style modifications required to effect weight-loss, which constitutes an essential healthcare intervention in this patient population, the use of adjunctive pharmacotherapeutic agents is often required. This article provides an overview of the first injectable treatment option, namely liraglutide, in the management of obesity, or of patients that are overweight in the presence of significant co-morbid conditions.
 
Publisher AOSIS
 
Contributor
Date 2016-05-01
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article —
Format application/pdf
Identifier 10.4102/safp.v58i3.4496
 
Source South African Family Practice; Vol 58, No 3 (2016): May/June; 3 2078-6204 2078-6190
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://safpj.co.za/index.php/safpj/article/view/4496/5342
 
Coverage — — —
Rights Copyright (c) 2016 Elmien Bronkhorst, Natalie Schellack https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT